TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Net Margin (2020 - 2026)

Updated

TScan Therapeutics' Net Margin came in at -5648.46% for Q3 2026, down 4226.32 percentage points from -1422.14% a year earlier and down 2759.88 percentage points from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Net Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, TScan Therapeutics reported Net Margin of -2219.92%, down 527.07 percentage points year-over-year; for FY2025, it came in at -1257.14%, up 3270.56 percentage points from FY2024.

  • Net Margin carries a five-year change of +1150.88 percentage points (FY2020 to FY2025).
  • Going back by year, Net Margin was -4527.70% in FY2024 (-4103.84 pp), -423.86% in FY2023 (+65.40 pp), -489.26% in FY2022 (-9.77 pp) and -479.49% in FY2021 (+1928.53 pp).
  • The Q3 2026 figure represents the lowest quarterly Net Margin since Q2 2024.
  • Year-over-year, Net Margin has declined for three consecutive quarters, with an average year-over-year change of +250.16 percentage points over the last eight quarters.
  • The fastest year-over-year change in Net Margin over five years came in Q2 2025 (a gain of 4705.60 percentage points), and the weakest in Q2 2024 (a drop of 5143.08 percentage points).
  • Business Quant data shows TCRX's Net Margin at -2888.58% (Q2 2026), -2919.14% (Q1 2026) and -895.99% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -973.44%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 26.44%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 0.83%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 24.24%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 28.01%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 37.28%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 29.27%
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -5,648.46%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -5,648.46%
Jun 30, 2026 -2,888.58%
Mar 31, 2026 -2,919.14%
Dec 31, 2025 -895.99%
Sep 30, 2025 -1,422.14%
Jun 30, 2025 -1,201.30%
Mar 31, 2025 -1,571.95%
Dec 31, 2024 -5,383.46%
Sep 30, 2024 -2,849.09%
Jun 30, 2024 -5,906.90%
Mar 31, 2024 -5,325.44%
Dec 31, 2023 -271.99%
Sep 30, 2023 -591.64%
Jun 30, 2023 -763.82%
Mar 31, 2023 -332.21%
Dec 31, 2022 -604.88%
Sep 30, 2022 -483.05%
Jun 30, 2022 -372.21%
Mar 31, 2022 -536.25%
Dec 31, 2021 -497.55%
API Access

TScan Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=TCRX&period=max&api_key=YOUR_API_KEY